N Dror1, J Carbone1, F Haddad1, B Falk2,3, P Klentrou2,3, S Radom-Aizik4. 1. Pediatric Exercise and Genomics Research Center, Department of Pediatrics, School of Medicine, University of California Irvine, 101 Academy, Suite 150, Irvine, CA, 92617, USA. 2. Department of Kinesiology, Faculty of Applied Health Sciences, Brock University, St. Catharines, ON, Canada. 3. Centre for Bone and Muscle Health, Brock University, St. Catharines, ON, Canada. 4. Pediatric Exercise and Genomics Research Center, Department of Pediatrics, School of Medicine, University of California Irvine, 101 Academy, Suite 150, Irvine, CA, 92617, USA. saizik@uci.edu.
Abstract
BACKGROUND: Recreational cycling is a popular activity which stimulates and improves cardiovascular fitness. The corresponding benefits for bone are unclear. PURPOSE: This study examined the effect of running (high-impact) vs. cycling (low-impact), at the same moderate-to-vigorous exercise intensity, on markers of bone formation (N-terminal propeptide of type I collagen, PINP) and bone resorption (C-telopeptide of type I collagen, CTX-1), a non-collagenous bone remodeling marker (osteocalcin), as well as bone-modulating factors, including parathyroid hormone (PTH), irisin (myokine) and sclerostin (osteokine). METHODS: Thirteen healthy men (23.7 ± 1.0 y) performed two progressive exercise tests to exhaustion (peak VO2) on a cycle ergometer (CE) and on a treadmill (TM). On subsequent separate days, in randomized order, participants performed 30-min continuous running or cycling at 70% heart rate reserve (HRR). Blood was drawn before, immediately post- and 1 h into recovery. RESULTS: PTH transiently increased (CE, 51.7%; TM, 50.6%) immediately after exercise in both exercise modes. Sclerostin levels increased following running only (27.7%). Irisin increased following both running and cycling. In both exercise modes, CTX-1 decreased immediately after exercise, with no significant change in PINP and osteocalcin. CONCLUSION: At the same moderate-to-vigorous exercise intensity, running appears to result in a greater transient sclerostin response compared with cycling, while the responses of bone markers, PTH and irisin are similar. The longer-term implications of this differential bone response need to be further examined.
BACKGROUND: Recreational cycling is a popular activity which stimulates and improves cardiovascular fitness. The corresponding benefits for bone are unclear. PURPOSE: This study examined the effect of running (high-impact) vs. cycling (low-impact), at the same moderate-to-vigorous exercise intensity, on markers of bone formation (N-terminal propeptide of type I collagen, PINP) and bone resorption (C-telopeptide of type I collagen, CTX-1), a non-collagenous bone remodeling marker (osteocalcin), as well as bone-modulating factors, including parathyroid hormone (PTH), irisin (myokine) and sclerostin (osteokine). METHODS: Thirteen healthy men (23.7 ± 1.0 y) performed two progressive exercise tests to exhaustion (peak VO2) on a cycle ergometer (CE) and on a treadmill (TM). On subsequent separate days, in randomized order, participants performed 30-min continuous running or cycling at 70% heart rate reserve (HRR). Blood was drawn before, immediately post- and 1 h into recovery. RESULTS: PTH transiently increased (CE, 51.7%; TM, 50.6%) immediately after exercise in both exercise modes. Sclerostin levels increased following running only (27.7%). Irisin increased following both running and cycling. In both exercise modes, CTX-1 decreased immediately after exercise, with no significant change in PINP and osteocalcin. CONCLUSION: At the same moderate-to-vigorous exercise intensity, running appears to result in a greater transient sclerostin response compared with cycling, while the responses of bone markers, PTH and irisin are similar. The longer-term implications of this differential bone response need to be further examined.
Authors: Wendy M Kohrt; Susan A Bloomfield; Kathleen D Little; Miriam E Nelson; Vanessa R Yingling Journal: Med Sci Sports Exerc Date: 2004-11 Impact factor: 5.411
Authors: Eimear Dolan; Ian Varley; Kathryn E Ackerman; Rosa Maria R Pereira; Kirsty Jayne Elliott-Sale; Craig Sale Journal: Exerc Sport Sci Rev Date: 2020-04 Impact factor: 6.230
Authors: Riku Nikander; Harri Sievänen; Ari Heinonen; Robin M Daly; Kirsti Uusi-Rasi; Pekka Kannus Journal: BMC Med Date: 2010-07-21 Impact factor: 8.775
Authors: D Bauer; J Krege; N Lane; E Leary; C Libanati; P Miller; G Myers; S Silverman; H W Vesper; D Lee; M Payette; S Randall Journal: Osteoporos Int Date: 2012-07-14 Impact factor: 4.507
Authors: Alexander G Robling; Paul J Niziolek; Lee A Baldridge; Keith W Condon; Matthew R Allen; Imranul Alam; Sara M Mantila; Jelica Gluhak-Heinrich; Teresita M Bellido; Stephen E Harris; Charles H Turner Journal: J Biol Chem Date: 2007-12-17 Impact factor: 5.157
Authors: Eimear Dolan; Alina Dumas; Karen M Keane; Giulia Bestetti; Luisa Helena Mavalli Freitas; Bruno Gualano; Wendy M Kohrt; George A Kelley; Rosa Maria Rodrigues Pereira; Craig Sale; Paul A Swinton Journal: Sports Med Date: 2022-07-23 Impact factor: 11.928
Authors: Patrick Lau; Åsa Beijer; André Rosenberger; Eckhard Schoenau; Christoph Stephan Clemen; Jochen Zange; Jörn Rittweger Journal: Int J Environ Res Public Health Date: 2021-09-18 Impact factor: 3.390